Chang Liu

Chang Liu

Auto-generated profile, based on publicly available information

Chang Liu

Department Chinese Medicine Authentication, Faculty of Pharmacy, Naval Medical University, Shanghai 200433, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2019 in Medical Science Monitor
Verified
Journal Article
Open access
CLChang Liu
Chang Liu
HLHai-Feng Li
Hai-Feng Li
JJJia Jia
Jia Jia
XRXinjian Ruan
Xinjian Ruan
YLYanfang Liu
Yanfang Liu
XZXia Zhang
Xia Zhang
BACKGROUND In present study, we explored the function of the metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) gene in the development of non-small cell lung cancer (NSCLC). MATERIAL AND METHODS qRT-PCR was used to detect the MALAT1 mRNA expression level in cancer tissues and adjacent normal tissues of 115 NSCLC patients and in cell lines. MALAT1-mimic, MALAT1-inhibitor, and corresponding negative controls (NC) were utilized to transfect the H460 cells. Proliferation, migration, and invasion of H460 cells were evaluated by MTT method and Transwell assay. Expression levels of proteins in the ERK/MAPK signaling pathway were assessed by Western blot analysis. RESULTS MALAT1 mRNA was upregulated in NSCLC tissues and cell lines compared to that in adjacent tissues and normal human bronchial cell line (BEAS-2B), respectively. Overexpression of MALAT1 significantly strengthened the proliferation, migration, and invasion ability of H460 cells. In comparison with the NC group, expression levels of CXCL5 and p-JNK proteins were elevated, while p-MAPK and p-ERK proteins were decreased in the MALAT1-mimic group. MALAT1 targets the 3'- untranslated region (UTR) fragment of the CXCL5 gene and inhibits its translation. Disturbance of the CXCL5 gene can reduce the protein expression of MAPK, p-MEK1/2, p-ERK1/2, and p-JNK, and inhibit the proliferation, migration, and invasion of MALAT1-mimic cells. CONCLUSIONS High MALAT1 expression promotes the proliferation, migration, and invasion of non-small cell lung cancer via the ERK/MAPK signaling pathway.

8 October 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
CMChao Ma
Chao Ma
YGYongwei Gu
Yongwei Gu
CLChang Liu
Chang Liu
XTXiaomeng Tang
Xiaomeng Tang
JYJianchao Yu
Jianchao Yu
JLJiyong Liu
Jiyong Liu

25 February 2025 in Phytomedicine
Verified
Journal Article
Closed access
JLJingchu Li
Jingchu Li
SLShanshan Liu
Shanshan Liu
JCJian Chen
Jian Chen
HWHanxue Wang
Hanxue Wang
XFXia Feng
Xia Feng
CMChao Ma
Chao Ma

25 June 2023 in Biomedical Chromatography
Verified
Journal Article
Closed access
CZChengzhong Zhang
Chengzhong Zhang
QBQitao Bu
Qitao Bu
CLChunyan Li
Chunyan Li
PLPengfei Lu
Pengfei Lu
CLChang Liu
Chang Liu
BHBaokang Huang
Baokang Huang

20 May 2024 in Biomedical Chromatography
Verified
Journal Article
Closed access
YLYuan Lin
Yuan Lin
HWHongqiang Wang
Hongqiang Wang
SXShihui Xu
Shihui Xu
CLChang Liu
Chang Liu
CZChengzhong Zhang
Chengzhong Zhang

30 August 2023 in Heliyon
Verified
Journal Article
Open access
XMXiangqing Meng
Xiangqing Meng
HWHongrui Wang
Hongrui Wang
ZKZhixuan Kuang
Zhixuan Kuang
YWYujie Wu
Yujie Wu
XSXiaohui Su
Xiaohui Su
MJMin Jia
Min Jia
Viticis Fructus (called Manjingzi in China) is the dried ripe fruits of the plant species Vitex trifolia subsp. litoralis Steenis and Vitex trifolia L. in the family Lamiaceae. Viticis Fructus has been used as a traditional Chinese medicine for thousands of years to treat illness such as colds, headache, vertigo, anesthesia, and hyperkinesias. More chemical constituents and medicinal effects have been discovered in Viticis Fructus with the development of modern technology. The aim of the review: This review aims to analyze the research progress of Viticis Fructus from the aspects of botany, ethnopharmacology, phytochemistry, and pharmacological activity, as well as to provide an outlook on the research and use prospects of Viticis Fructus. A comprehensive literature search using online databases such Science Direct, CNKI, Wiley online library, Spring Link, Web of Science, PubMed, Wanfang Data and SCI-Finder. In addition, information was obtained from local and foreign books on ethnobotany and ethnomedicine. The application of Viticis Fructus as a medicine can be traced back to around 480 AD. So far, more than 190 compounds have been isolated from Viticis Fructus, including flavonoids, sterols, cyclic enol ether terpenoids, and diterpenoids. Modern pharmacological studies have shown that the extracts of Viticis Fructus have various pharmacological effects, such as anti-allergic, antioxidant, anti-inflammatory, anti-cancer, and anti-bacterial effects. As a widely used traditional medicine, Viticis Fructus is rich in chemical compositions and has an obvious biological activity. However, the application and pharmacological activity of Viticis Fructus have not been scientifically evaluated or convincing due to poor methodology, unclear results and lack of clinical data. Systematic and comprehensive research evaluations are needed to verify its pharmaceutical activity, clinical therapeutic efficacy and safety. As an important herbal medicine, it should be further explored to facilitate the development of new medicines and treatments for a variety of diseases.